CSIMarket
 


Scpharmaceuticals Inc   (SCPH)
Other Ticker:  
 
 

SCPH's Capital Expenditures Growth by Quarter and Year

Scpharmaceuticals Inc 's Capital Expenditures results by quarter and year




SCPH Capital Expenditures (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 0.00 0.00 0.00
III Quarter September 0.02 0.01 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.01 0.00 0.00 0.00
FY   0.03 0.01 0.00 0.00



SCPH Capital Expenditures third quarter 2022 Y/Y Growth Comment
Scpharmaceuticals Inc showed record Capital Expenditures increase in the third quarter 2022 with 50% from the third quarter 2022 2021, to $ 0.02 millions.

Looking into third quarter 2022 results within Major Pharmaceutical Preparations industry 83 other companies have achieved higher Capital Expenditures growth. While Scpharmaceuticals Inc ' s Capital Expenditures jump of 50% ranks overall at the positon no. 979 in the third quarter 2022.




SCPH Capital Expenditures ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September 50 % - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Scpharmaceuticals Inc 's third quarter 2022 Capital Expenditures $ 0.02 millions SCPH's Income Statement
Scpharmaceuticals Inc 's third quarter 2021 Capital Expenditures $ 0.01 millions Quarterly SCPH's Income Statement
New: More SCPH's historic Capital Expenditures Growth >>


SCPH Capital Expenditures (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Capital Expenditures third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #84
Healthcare Sector #205
Overall #979

Capital Expenditures Y/Y Growth Statistics
High Average Low
50 % -25 % -100 %
(Sep 30 2022)   (Jun 30 2019)
Capital Expenditures third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #84
Healthcare Sector #205
Overall #979
Capital Expenditures Y/Y Growth Statistics
High Average Low
50 % -25 % -100 %
(Sep 30 2022)   (Jun 30 2019)

Capital Expenditures by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Scpharmaceuticals Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
-100 % -100 % -100 %
(Jun 30 2022)  


SCPH's III. Quarter Q/Q Capital Expenditures Comment


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Capital Expenditures Q/Q Growth Statistics
High Average Low
-100 % -100 % -100 %
(Jun 30 2022)  


SCPH's III. Quarter Q/Q Capital Expenditures Comment


Scpharmaceuticals Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Capital Expenditures Growth (TTM) - - - - -
Year on Year Capital Expenditures Growth Overall Ranking # # # # #
Seqeuential Capital Expenditures Change (TTM) - - - - -
Seq. Capital Expenditures Growth (TTM) Overall Ranking # # # # #




Cumulative Capital Expenditures growth Comment
In the Sep 30 2022 period, Scpharmaceuticals Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Scpharmaceuticals Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Capital Expenditures growth Comment
In the Sep 30 2022 period, Scpharmaceuticals Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Scpharmaceuticals Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Capital Expenditures Growth
Major Pharmaceutical Preparations Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
SCPH's Capital Expenditures Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for SCPH's Competitors
Capital Expenditures Growth for Scpharmaceuticals Inc 's Suppliers
Capital Expenditures Growth for SCPH's Customers

You may also want to know
SCPH's Annual Growth Rates SCPH's Profitability Ratios SCPH's Asset Turnover Ratio SCPH's Dividend Growth
SCPH's Roe SCPH's Valuation Ratios SCPH's Financial Strength Ratios SCPH's Dividend Payout Ratio
SCPH's Roa SCPH's Inventory Turnover Ratio SCPH's Growth Rates SCPH's Dividend Comparisons



Companies with similar Capital Expenditures jump for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Sep 30 2022
Inozyme Pharma Inc 86.08%$ 86.076 millions
Orthofix Medical Inc 85.92%$ 85.915 millions
Orion Energy Systems Inc 85.89%$ 85.890 millions
Vicarious Surgical Inc 85.31%$ 85.308 millions
Exagen Inc 85.05%$ 85.053 millions
Livanova Plc84.68%$ 84.684 millions
Elanco Animal Health Inc84.00%$ 84.000 millions
Eli Lilly And Company83.25%$ 83.254 millions
Nanoviricides inc 83.05%$ 83.054 millions
Geron Corp81.91%$ 81.915 millions
Zynex inc 81.82%$ 81.818 millions
Biomarin Pharmaceutical Inc79.13%$ 79.131 millions
Invitae Corporation79.06%$ 79.056 millions
Rayont Inc 78.49%$ 78.491 millions
Gain Therapeutics inc78.00%$ 78.000 millions
Caribou Biosciences Inc 77.85%$ 77.849 millions
Oncorus Inc 75.34%$ 75.343 millions
Coherus Biosciences inc 75.10%$ 75.096 millions
Trevena inc 75.00%$ 75.000 millions
Acadia Healthcare Company Inc 74.83%$ 74.825 millions
Cellectar Biosciences Inc 73.91%$ 73.911 millions
Xenon Pharmaceuticals Inc 73.09%$ 73.094 millions
Progyny Inc 72.70%$ 72.702 millions
Kodiak Sciences Inc 71.32%$ 71.322 millions
Abcellera Biologics Inc 69.27%$ 69.268 millions
Isoray Inc 66.67%$ 66.667 millions
Star Equity Holdings Inc 63.70%$ 63.699 millions
Arvinas Inc 63.20%$ 63.196 millions
Beigene Ltd 62.07%$ 62.068 millions
1life Healthcare Inc 62.04%$ 62.039 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PE's Profile

Stock Price

PE's Financials

Business Description

Fundamentals

Charts & Quotes

PE's News

Suppliers

PE's Competitors

Customers & Markets

Economic Indicators

PE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071